Aug. 13, 2024
The National Institutes of Health (NIH) recently announced the NIH RADx® Tech ACT ENDO Challenge, a new initiative intended to accelerate the development of innovative technologies, such as imaging technologies, for diagnosing endometriosis.

The challenge offers up to $3 million to shorten the time to diagnose, eliminate the invasiveness of current techniques, and/or improve accessibility, safety, convenience and costs of diagnosis. This initiative is co-led by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

The ACT ENDO Challenge seeks innovative and non-invasive solutions, in addition to imaging technologies, including in vitro diagnostic devices, clinical laboratory tests, wearable devices, smartphone-enabled diagnostic tools, integrated sensing technologies and digital health platforms.

This two-year challenge will consist of three phases. Submissions to Phase I are due Oct. 11, and final winners are expected to be announced in March 2026. Teams may include start-ups, small- or mid-size businesses, non-profit organizations and academic institutions. Find more information online, including details about eligibility, rules and how to register.

For more information, contact Katie Grady, American College of Radiology® Government Affairs Director.

Related ACR News

  • ACR Urges Agencies to Issue Final NSA IDR Operations Rule

    ACR, ACEP and ASA urge federal agencies to finalize the No Surprises Act IDR rule to improve payer-provider communication and streamline disputes.

    Read more
  • 2026 Radiology Coding Updates Now Available

    ACR Coding Resources now reflect 2026 CPT®️ updates for radiology, including new, revised, and deleted codes with full descriptors.

    Read more
  • 2024 MIPS Scores Available in Quality Payment Program Portal

    MIPS 2024 scores and payment info are now on the QPP portal. Dispute errors via targeted review by Nov. 14, 8 PM ET.

    Read more